In this episode of Neuro Innovation Talks, the newest podcast series in the DeviceTalks Podcast Network, the DeviceTalks editors invite Johnson & Johnson MedTech Neurovascular's Head of Global Marketing, John Murray to take over the podcast studio and bring to light the stories from the pioneering neurointerventionalists who have helped shape the stroke industry.

In the first episode, Host John Murray sits down with Alejandro Berenstein, MD, Professor of Neurosurgery, Pediatrics and Radiology, Director of pediatric Cerebrovascular Surgery, Mount Sinai Health System, to discuss the incredible evolution of neurovascular surgery and its impact on modern healthcare. Dr. Berenstein shares his early inspirations, key breakthroughs, and the significant role mentors played in shaping his illustrious career. Highlighting landmark projects like the pioneering treatments for Vein of Galen Malformations (VOGM) and facial vascular anomalies, Dr. Berenstein shares the complexities and triumphs of his work. His story provides a blueprint for aspiring medical professionals and innovators, demonstrating how personal experiences, visionary thinking, and collaborative efforts can lead to groundbreaking advancements that significantly impact patient outcomes.
Thank you to Zeus for sponsoring this episode of Neuro Innovation Talks. To learn more about how Zeus supports medical device companies, visit: www.zeusinc.com.

Special thanks to the following for their support in the development of this podcast: Joanna Colangelo, Johanna Fifi, Whitney Garrett, Howard Riina, Lillian Medina, and J. Mocco.

Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode.

Thank you for supporting the Neuro Innovation Talks podcast!

J&J MedTech’s John Murray and Dr. Berenstein on the early evolution of neurovascular treatments

In this episode of AbbottTalks, Sandra Lesenfants, SVP of Abbott’s structural heart business, discusses the latest advancements in structural heart care, focusing on Abbott's transformative TriClip device for tricuspid regurgitation.

Lesenfants highlights Abbott’s commitment to patient-centered innovation, emphasizing the importance of creating solutions that meet patients’ needs through safe and effective technologies. She also shares Abbott’s approach to expanding access to minimally invasive therapies, particularly in underserved populations worldwide, and the role of physician partnerships in advancing structural heart interventions.

Lastly, Lesenfants underscores the company’s efforts to increase diversity in clinical trials, noting the importance of intentional inclusivity across gender and ethnicity to better serve diverse patient populations.

Thank you to Confluent Medical Technologies for sponsoring this episode of AbbottTalks. For more information on how Confluent Medical works with medical device companies, visit https://confluentmedical.com/.

Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

Abbott’s Lesenfants shares TriClip progress, patient-centered innovation & clinical trial diversity

The DeviceTalks Podcast Network delivers news, insights and commentary from MedTech industry leaders, primarily from the largest OEMs in healthcare. Our podcasts will inspire MedTech professionals to create better MedTech devices and companies.

Explore the DeviceTalks Podcast Network, home to more than 11 podcasts:

• DeviceTalks Weekly
• AbbottTalks
• Boston Scientific Talks
• DeviceTalks AI
• IntuitiveTalks
• MedtechWOMEN Talks
• MedtronicTalks
• Neuro Innovation Talks: J&J MedTech Neuro
• Structural Heart Talks: Edwards Lifesciences
• Ortho Innovation Talks: Zimmer Biomet
• StrykerTalks

WATCH our video podcasts on www.youtube.com/@DeviceTalks

Connect with the hosts:
Tom Salemi, Editorial Director, DeviceTalks https://www.linkedin.com/in/tom-salemi-7118948/
Kayleen Brown, Managing Editor, DeviceTalks https://www.linkedin.com/in/kayleenbrown/

Learn more about DeviceTalks - Podcasts • Conferences • Webinars - www.devicetalks.com

J&J MedTech’s John Murray and Dr. Berenstein on the early evolution of neurovascular treatments

DeviceTalks

Related tracks